http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-665675-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40824c489e71a02b85c9c7227fb75fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c526f3fe15af05ec67c1129d435da5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be2c0e7d5d864616741472d3169c7a58
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02
filingDate 1948-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1952-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-665675-A
titleOfInvention Process for the manufacture of derivatives of hydroxy acids
abstract Acylamido-salicylic acids of the formula <FORM:0665675/IV (b)/1> where R1 and R2 are hydrogen or alkyl and n is an integer are prepared by treating the halogen compounds <FORM:0665675/IV (b)/2> where X is a halogen, with ammonia or primary or secondary amines. Suitable amines are ethylamine, diethylamine, isopropylamine, butylamines, amylamines, laurylamine, stearylamine and palmitylamine; when a secondary amine is used R1 and R2 may be the same or different. The halogen compounds may be the a -chloro- or bromo-acetamido, propionamido or butyramido derivatives. The reaction is preferably carried out at low temperatures to minimise hydrolysis of the acylamido group. A solvent such as alcohol may be present, together with copper, copper-bronze, or a copper salt as catalyst. The product is conveniently isolated as a salt such as the hydrochloride. The starting materials can be prepared as in Specification 664,363. Examples show the preparation of 4-glycylamido-salicylic acid and 4-diethylaminoacetamido-salicylic acid.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2644697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9011292-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2427327-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9011292-A3
priorityDate 1948-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429259640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153782463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419769253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420070381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8021

Total number of triples: 41.